Laurel Wealth Advisors (North Carolina)’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,500	Closed	-$9.25K	–	332
2025 Q4	$9.25K	Buy	+2,500	New	+$8.08K	﹤0.01%	493
2025 Q2	–	Sell	-2,500	Closed	-$3.6K	–	336
2025 Q1	$3.6K	Hold	2,500	–	–	﹤0.01%	565
2024 Q4	$5.5K	Hold	2,500	–	–	﹤0.01%	542
2024 Q3	$4.13K	Hold	2,500	–	–	﹤0.01%	535
2024 Q2	$5.55K	Hold	2,500	–	–	﹤0.01%	472
2024 Q1	$6.7K	Hold	2,500	–	–	﹤0.01%	466
2023 Q4	$7.47K	Hold	2,500	–	–	﹤0.01%	423
2023 Q3	$2.45K	Hold	2,500	–	–	﹤0.01%	502
2023 Q2	$3.48K	Hold	2,500	–	–	﹤0.01%	486
2023 Q1	$3.98K	Hold	2,500	–	–	﹤0.01%	474
2022 Q4	$15.6K	Hold	2,500	–	–	﹤0.01%	352
2022 Q3	$17K	Hold	2,500	–	–	﹤0.01%	346
2022 Q2	$16K	Hold	2,500	–	–	﹤0.01%	348
2022 Q1	$12K	Hold	2,500	–	–	﹤0.01%	392
2021 Q4	$13K	Hold	2,500	–	–	﹤0.01%	385
2021 Q3	$30K	Hold	2,500	–	–	0.01%	305
2021 Q2	$53K	Hold	2,500	–	–	0.01%	274
2021 Q1	$70K	Hold	2,500	–	–	0.02%	236
2020 Q4	$65K	Sell	2,500 -240	-9%	-$7.19K	0.02%	236
2020 Q3	$102K	Buy	2,740 +2,500	+1,042%	+$99K	0.03%	178
2020 Q2	$12K	Hold	240	–	–	﹤0.01%	359
2020 Q1	$8K	Hold	240	–	–	﹤0.01%	380
2019 Q4	$14K	Hold	240	–	–	﹤0.01%	355
2019 Q3	$9K	Hold	240	–	–	﹤0.01%	390
2019 Q2	$11K	Hold	240	–	–	﹤0.01%	364
2019 Q1	$10K	Hold	240	–	–	﹤0.01%	368
2018 Q4	$11K	Buy	+240	New	+$11.6K	﹤0.01%	340